US FDA’s Best Year Ever For New Drugs: CDER Novel Approvals Hit 59

FDA’s drug center smashes its past records for new molecular entities and therapeutic biologic approvals; with five novel biologics approved by FDA’s biologics center, the agency’s novel approvals reach a stunning total of 64. 

Picture showing group of friends having fun with sparklers - Image
FDA may be partially shutdown, but the agency should still celebrate its drug approval totals for 2018.

More from Approvals

More from Product Reviews